“Critical Review of the Pivotal Studies of Four rFVIII Products for the Treatment of Hemophilia A Patients: The Role of Octocog Alfa”, FE, vol. 21, no. 1, Apr. 2020, doi: 10.7175/fe.v21i1.1453.